Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 15 clinical trials
Testosterone Therapy in Men With Low Testosterone Levels and Metabolic Syndrome or Early Stages of Type 2 Diabetes

the study is to evaluate if normalisation of serum testosterone levels in men with metabolic syndrome (Abdominal obesity, hypertension, dyslipidemia, insulin resistance and pre-diabetes or

plasma glucose
body mass index
central obesity
hypogonadism
oral glucose tolerance test
  • 232 views
  • 07 Nov, 2020
  • 1 location
Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer

This is a trial for patients with newly diagnosed metastatic prostate cancer with 5 or fewer sites of metastases. The trial involves surgery (removal of the prostate), six months of hormone therapy, and stereotactic body radiotherapy to the sites of metastasis.

  • 1 views
  • 26 Oct, 2020
  • 3 locations
A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer

The purpose of this study is to determine the efficacy and safety of relugolix 120 milligrams (mg) orally once daily for 48 weeks on maintaining serum testosterone suppression to castrate levels

metastasis
serum testosterone
leuprolide
cryotherapy
prostatectomy
  • 1590 views
  • 04 Nov, 2020
  • 352 locations
Effect of Testosterone Treatment on Embryo Quality

pregnancy rates among women with evidence of diminished ovarian reserve that have persistently low serum testosterone and free testosterone after completing six previous weeks of DHEA supplementation.

follicle stimulating hormone
dhea
diminished ovarian reserve
dehydroepiandrosterone
  • 333 views
  • 21 Nov, 2020
  • 2 locations
Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients

receive a single intramuscular depot injection of testosterone approximately 7 days after triptorelin treatment. This depot administration will keep the serum testosterone on a normal level until the next

  • 29 views
  • 17 Jan, 2021
  • 8 locations
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer

The goal of this study is to find out if patients with prostate cancer being treated with the medications abiraterone and prednisone can discontinue hormone injections (examples include leuprolide, goserelin, triptorelin and degarelix). Abiraterone and prednisone are pills used to treat patients with prostate cancer. When abiraterone and prednisone are …

triptorelin
degarelix
metastatic prostate cancer
leuprolide
cancer
  • 8 views
  • 23 Jan, 2021
  • 1 location
Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic Signature

The primary objective is to test the following hypothesis: Patients with metastatic castrate resistant prostate cancer that have progressed following at least one line of therapy and have an immunogenic signature will respond to combined PD-1 and CTLA4 inhibition.

serum testosterone
tumor progression
adenocarcinoma of prostate
adenocarcinoma
androgens
  • 104 views
  • 23 Jan, 2021
  • 1 location
Goserelin Acetate Sustained Release Microspheres Injection LY01005 for Prostate Cancer

This is a multicenter, randomized and open label Phase Clinical Study, comparing the efficacy and safety of LY01005 with Zoladex in patients with prostate cancer.

  • 0 views
  • 30 Sep, 2020
  • 1 location
RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)

Single-arm, single site, open label study of the effects of parenteral testosterone followed by enzalutamide, abiraterone or castration-only therapy in men with metastatic CRPC who previously progressed on one of these forms of therapy. The study will enroll four cohorts of patients: men with metastatic CRPC who have progressed on …

PTEN
arn-509
endocrine therapy
nilutamide
antiandrogen therapy
  • 14 views
  • 20 May, 2020
  • 2 locations
Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients

Androgen deprivation therapy (ADT) is a mainstay of prostate cancer treatment to improve overall survival for intermediate- and high-risk localized disease as well as metastatic disease. While ADT improves survival, it can cause significant morbidity and a decrement in quality of life. In particular, ADT is associated with decrease in …

triptorelin
metastasis
degarelix
metastatic prostate cancer
leuprolide
  • 5 views
  • 29 Mar, 2020
  • 10 locations